Allison Luo
2021
In 2021, Allison Luo earned a total compensation of $4.2M as Chief Medical Officer at Prometheus Biosciences, a 305% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $364,800 |
|---|---|
| Option Awards | $3,407,763 |
| Salary | $450,187 |
| Other | $12,986 |
| Total | $4,235,736 |
Luo received $3.4M in option awards, accounting for 80% of the total pay in 2021.
Luo also received $364.8K in non-equity incentive plan, $450.2K in salary and $13K in other compensation.
Rankings
In 2021, Allison Luo's compensation ranked 3,143rd out of 12,406 executives tracked by ExecPay. In other words, Luo earned more than 74.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,143 out of 12,406 | 75th |
Division Manufacturing | 1,267 out of 5,494 | 77th |
Major group Chemicals And Allied Products | 516 out of 2,369 | 78th |
Industry group Drugs | 457 out of 2,090 | 78th |
Industry Pharmaceutical Preparations | 315 out of 1,537 | 80th |
Source: SEC filing on April 1, 2022.
Luo's colleagues
We found three more compensation records of executives who worked with Allison Luo at Prometheus Biosciences in 2021.